Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
NCT ID: NCT06293651
This clinical trial is investigating a new treatment called DA-4505, both on its own and together with another medication called Pembrolizumab, for adults with locally advanced or metastatic solid ...
Recruiting
Phase: PHASE1
Type: interventional
Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of